Fierce Pharma reports:

Poland, Romania must pay Pfizer $2.2B in fight over contested COVID vaccine doses: Belgian court

The Von der Leyen vaccines are left over from the enormous deal the EU did with Pfizer.

The vaccine order debacle stems back to a massive COVID supply deal from the European Commission in May 2021, covering 900 million vaccine doses for delivery split between 2022 and 2023. European officials exercised an option for more doses in December of 2021, signing on to receive another 200 million doses slated for delivery in 2022. The agreement was later investigated by Europe’s Court of Auditors based on the nature of the negotiations and concerns over text messages between European Commission President Ursula von der Leyen and Pfizer’s CEO, Albert Bourla, in the lead-up to the deal.

This is a lot of money for any country to pay for a warehouse full of vaccines that no-one will ever use as they will either be expired or redundant as new vaccines will be pushed in the next pandemic.

All of this as a result of a leak from a western-funded gain-of-function biolab in Wuhan, China where they had been messing around with the COVID virus for years.